Company: BSX
Filing Date: 2025-08-01
Form Type: 10-Q
Source: 0000885725-25-000041
Chunk: 118

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-08-01
Form: 10-Q
Item: Part I, Item 8
Chunk 118
---
 at cost less impairment, if any, adjusted to fair value for any observable price changes in orderly transactions for the identical or a similar investment of the same issuer, recognized in Other, net within our accompanying unaudited consolidated statements of operations.(2) Includes publicly-held equity securities measured at fair value with changes in fair value recognized in Other, net within our accompanying unaudited consolidated statements of operations.These investments are classified as Other long-term assets within our accompanying unaudited consolidated balance sheets, in accordance with GAAP and our accounting policies. 

As of June 30, 2025, the cost of our aggregated equity method investments exceeded our share of the underlying equity in net assets by $321 million, which represents amortizable intangible assets, in-process research and development (IPR&D), goodwill and deferred tax liabilities. 

12

NOTE C – GOODWILL AND OTHER INTANGIBLE ASSETS The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:As of June 30, 2025As of December 31, 2024(in millions)Gross Carrying AmountAccumulated Amortization/ Write-offsGross Carrying AmountAccumulated Amortization/ Write-offsTechnology-related$14,530 $(8,949)$14,327 $(8,605)Patents483 (381)481 (381)Other intangible assets2,433 (1,670)2,380 (1,612)Amortizable intangible assets$17,446 $(11,000)$17,188 $(10,598)    Goodwill$27,976 $(9,900)$26,989 $(9,900)IPR&D$813 $94 Indefinite-lived intangible assets$813 $94 The increase in our balance of goodwill and intangible assets is related primarily to our acquisition of Cortex in the first quarter of 2025, and Bolt Medical, Intera and SoniVie in the second quarter of 2025. The following represents a roll forward of our goodwill balance by reportable segment:(in millions)MedSurgCardiovascularTotalBalance as of December 31, 2024$7,483 $9,606 $17,089 Goodwill acquired— 853 853 Impact of foreign currency fluctuations and purchase price adjustments43 92 134